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ABSTRACT 
Acute inflammation in the bowel, a response of the immune system to infections or trauma, 
is probably a frequent but localized event, but when the barrier is repaired and the infection 
cleared, it is quickly followed by wound healing and resolution.  However, in some 
individuals these mechanisms are not effective and the inflammatory bowel diseases, 
Crohn’s disease and ulcerative colitis result. Common and important characteristics in both 
of these diseases are the increased accumulation of immune cells, especially non-apoptotic 
CD4+ T cells and the activation of non-immune cells, including fibroblasts, which then 
become directly involved in immune responses.  
The aim of this thesis was to improve our understanding of the role of the mucosal 
fibroblasts in intestinal inflammation by analysing the molecular signalling mechanisms 
underlying their inflammatory potential. Fibroblast cell lines isolated from murine normal 
colon tissue and from the CD4+CD45RBhigh –transplanted SCID mouse model of colitis 
were used.  
Fibroblasts are known to express the membrane receptor CD40 which, through interaction 
with its ligand (CD40L), plays a key role in inflammatory responses.  We showed for the 
first time the existence of a subpopulation of fibroblasts isolated from inflamed tissue 
which, despite having lower expression of membrane CD40 compared to normal 
fibroblasts, were able to respond vigorously to CD40 ligation, a response that was increased 
by IFN-γ.   This indicated that the activated fibroblasts in colitis acquire a permanently 
activated phenotype. 
Molecular studies performed to reveal the mechanisms underlying the synergy between 
CD40 and IFN-γ in inflamed cells, revealed co-operation between the transcription factors 
CAATT/Enhancer binding protein beta (C/EBPβ) and Nuclear Factor kappa B (NFκB). 
Both transcription factors were expressed constitutively at higher intensity in inflamed 
fibroblasts, compared to normal cells, rendering inflamed mucosal fibroblasts more 
sensitive to CD40 ligation and IFN-γ stimulation. 
Co-cultures of normal and inflamed fibroblasts with CD4+ T cells showed that both 
fibroblast lines were equally efficient in promoting survival of CD4+ T cells, thus indicating 
the importance of the mesenchyme in immune homeostasis in the gut.  
Finally, analysis of TGF-β ligation on the fibroblast lines showed that the increased and 
disrupted collagen deposition which had been observed in inflamed tissue could not be 
explained by simple dysregulation of signalling from the TGF-βR on inflamed fibroblasts.   
In conclusion, the results of this thesis suggest that mucosal fibroblasts in chronic 
inflammation respond to the surrounding milieu, become activated and transdifferentiate 
into a stable proinflammatory phenotype which may contribute to chronicity of the 
inflammation, and certainly influences its pathogenesis. 
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